Skip to main content
Screener/Healthcare/Drug Manufacturers - General

GILD Gilead Sciences, Inc.

NASDAQ
$151.41+1.23 (+0.82%)
$108.46
$157.29
$148.22
$152.09
EPS (TTM)$7.34
P/E Ratio20.55
Dividend Yield2.15%
Market Cap$187.34B
Volume3.05M
Prev Close$150.11
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$7.0B$2.0B$1.611.1%29.0%
Q4 '25$7.9B$2.2B$1.7486.8%27.5%
Q3 '25$7.8B$3.1B$2.4379.8%39.3%
Q2 '25$7.1B$2.0B$1.5678.8%27.7%
Q1 '25$6.7B$1.3B$1.0476.9%19.7%
Q4 '24$7.6B$1.8B$1.4279.1%23.6%
Q3 '24$7.5B$1.3B$1.0079.1%16.6%
Q2 '24$7.0B$1.6B$1.2977.8%23.2%
Get Your Daily Market Recap